Huxin Formula Inhibits Oxidized low-Density Lipoprotein-Induced Foam Cell Formation in THP-1 Macrophages via the LOX-1/NF-κB Pathway
Background Macrophage-derived foam cells are essential in the progression of atherosclerosis (AS). Based on our previous study, the Huxin Formula (HXF), a traditional Chinese medicine formula, demonstrates potential in anti-atherosclerosis. Nevertheless, it is still unknown how HXF affects the formation of foam cells derived from THP-1 macrophages. Purpose This research aims to examine the preventive role of HXF in the development of foam cells and its underlying molecular mechanism. Methods THP-1 derived macrophages and THP-1 cells overexpressing LOX-1 (LV-OLR1) were exposed to ox-LDL to establish foam cell models, and then treated with HXF. Meantime, Oil red O staining was used to detect lipid droplet production. ELISA kit was performed to measure intracellular levels of IL-6 and TGF-β. RT-qPCR and Western Blot were then utilized to determine the LOX-1 and NF-κB mRNA/protein levels. Results The findings indicated that HXF treatment potently reduced the lipid accumulation, downregulated IL-6 levels and upregulated TGF-β levels. However, this impact was almost reversed when LOX-1 was overexpressed in THP-1 cells stimulated with ox-LDL. Moreover, THP-1 were treated with HXF markedly reduced the levels of LOX-1 and NF-κB mRNA/protein, whereas overexpressing LOX-1 significantly reversed this effect. Conclusion HXF reduced the formation of foam cell in ox-LDL-stimulated THP-1 macrophages via inhibiting lipid accumulation and inflammation through regulating the LOX-1/ NF-κB pathway. These present findings further indicate a potential beneficial role of HXF in ameliorating atherosclerosis and foam cell formation, while provide a novel potential therapeutic strategy for preventing atherosclerosis.
Authors
- Xiaomin Ou (ORCID: https://orcid.org/0000-0001-9162-1950)
- Qiaohuang Zeng (ORCID: https://orcid.org/0000-0002-8844-3978)
- Wei Jiang (ORCID: https://orcid.org/0000-0003-0818-8784)
- Weihui Lu (ORCID: https://orcid.org/0000-0001-7754-2682)
- Tao-Hua Lan (ORCID: https://orcid.org/0000-0002-5393-9009)
- Jing Cai
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Nanfang Hospital (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
- Nanfang College Guangzhou
Publication Details
- Journal
- Natural Product Communications
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1177/1934578x241282836
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China